Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky.

Yehuda L Danon,Gerd Sutter, S A Plotkin

CLINICAL AND VACCINE IMMUNOLOGY（2015）

Cited 8|Views3
No score
Abstract
We read with some concern the report by Yokote et al. ([1][1]), in which the authors recommend that LC16m8, a replicating smallpox vaccine licensed in Japan, be considered for use in persons who are immunocompromised. The authors presented new data from mouse models comparing the virulence of LC16m8
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined